Sign In
Buy NVCN
$30.03
+0 (+0%)
At Close: Jul 07, 2023
Neovasc Inc. (TSE:NVC) to Post Q1 2021 Earnings of ($0.78) Per Share, SVB Leerink Forecasts
08:02am, Friday, 03'rd Apr 2020
Neovasc Inc. (TSE:NVC) (NASDAQ:NVCN) – Stock analysts at SVB Leerink issued their Q1 2021 earnings per share (EPS) estimates for Neovasc in a report issued on Tuesday, March 31st. SVB Leerink analys
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
12:00am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 2)
BELLUS Health Inc (NASDAQ:...
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
11:38am, Wednesday, 01'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs March 31)
Athersys Inc (NASDAQ: ATHX...
Analysts Are Bullish on These Healthcare Stocks: Neovasc (NVCN), Biohaven Pharmaceutical Holding Co (BHVN)
10:08am, Tuesday, 31'st Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neovasc (NVCN), Biohaven Pharmaceutical Holding Co (BHVN)
Canaccord Genuity Maintains Buy on Neovasc, Lowers Price Target to $3
12:00am, Tuesday, 31'st Mar 20205 Stocks Moving In Monday's After-Hours Session
08:47pm, Monday, 30'th Mar 2020
Losers
RH (NYSE: RH) shares are trading lower after the company reported Q4 earnings results. Q4 sales of $665 million were down from $670.89 million year over year.
Reata...
Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results
08:05pm, Monday, 30'th Mar 2020
VANCOUVER and MINNEAPOLIS, March 30, 2020 -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally.
Neovasc, Inc. to Host Earnings Call
06:30pm, Monday, 30'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 30, 2020 / Neovasc, Inc. (NASDAQ:NVCN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 30, 2020 at 4:30 PM Ea
Earnings Scheduled For March 30, 2020
08:13am, Monday, 30'th Mar 2020
Companies Reporting Before The Bell
Cal-Maine Foods, Inc. (NASDAQ: CALM) is projected to report quarterly earnings at $0.17 per share on revenue of $338.08 million.
HEXO Corp. (...
Neovasc Q4 EPS $(1.45) Down From $(0.77) YoY, Sales $565.821K Up From $523.424K YoY
12:00am, Monday, 30'th Mar 2020The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 24)
BELLUS Health Inc (...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Neovasc (NVC) to Release Quarterly Earnings on Monday
05:52am, Monday, 23'rd Mar 2020
Neovasc (TSE:NVC) (NASDAQ:NVCN) will be announcing its earnings results after the market closes on Monday, March 30th. Neovasc has a 1 year low of C$0.49 and a 1 year high of C$1.82. About Neovasc Neo
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASD
